Venous thromboembolism risk factor assessment and prophylaxis

被引：19
|
作者：
Henke, P. K.
Pannucci, C. J.
机构：
[1] Univ Michigan, Sect Vasc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sect Plast Surg, Ann Arbor, MI 48109 USA
来源：
PHLEBOLOGY | 2010年 / 25卷 / 05期
关键词：
CLINICAL SPECTRUM; D-DIMER; THROMBOSIS; PREVENTION; VALIDATION; ENOXAPARIN; PROXIMATE; DURATION; EVENTS; IMPACT;
D O I：
10.1258/phleb.2010.010018
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：219 / 223
页数：5
相关论文
共 50 条
  • [31] Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal
    Moesker, M. J.
    Damen, N. L.
    Volmeijer, E. E.
    Dreesens, D.
    de Loos, E. M.
    Vink, R.
    Coppens, M.
    Kruip, M. J.
    Meijer, K.
    Langelaan, M.
    de Bruijne, M. C.
    Wagner, C.
    THROMBOSIS RESEARCH, 2018, 168 : 5 - 13
  • [32] 81An Audit of Venous Thromboembolism (VTE) Risk Assessment & Prophylaxis Implementation
    Woolner, B.
    Moore, P.
    Parker, S.
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [33] Risk of Venous Thromboembolism in Patients with Chronic Liver Disease and the Utility of Venous Thromboembolism Prophylaxis
    Pincus, Kathleen J.
    Tata, Asha L.
    Watson, Kristin
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 873 - 878
  • [34] Two novel risk factors for postoperative venous thromboembolism: A reconsideration of standard risk assessment and prophylaxis
    Vaughn, Stephanie C.
    Talutis, Stephanie D.
    Cassidy, Michael R.
    Sachs, Teviah E.
    Drake, Frederick T.
    Rosenkranz, Pamela
    Rao, Sowmya R.
    McAneny, David
    AMERICAN JOURNAL OF SURGERY, 2020, 220 (05): : 1338 - 1343
  • [35] Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism
    Mana Mitsuguro
    Toshiyuki Sakata
    Akira Okamoto
    Sachika Kameda
    Yoshihiro Kokubo
    Yoshiaki Tsutsumi
    Michitaka Sano
    Toshiyuki Miyata
    International Journal of Hematology, 2010, 92 : 468 - 473
  • [36] Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism
    Mitsuguro, Mana
    Sakata, Toshiyuki
    Okamoto, Akira
    Kameda, Sachika
    Kokubo, Yoshihiro
    Tsutsumi, Yoshiaki
    Sano, Michitaka
    Miyata, Toshiyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) : 468 - 473
  • [37] Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer?
    White, R. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 543 - 545
  • [38] Assessment of the adherence to and costs of the prophylaxis protocol for venous thromboembolism
    Forgerini, Marcela
    Varallo, Fabiana Rossi
    Alves de Oliveira, Alice Rosa
    de Nada, Tales Rubens
    Mastroianni, Patricia de Carvalho
    CLINICS, 2019, 74
  • [39] RISK FACTOR ASSESSMENT OF VENOUS THROMBOEMBOLISM (VTE) IN CRITICALLY ILL CHILDREN
    Reiter, Pamela D.
    Wathen, Beth
    Schultz, Lynn
    Valuck, Robert
    Allen, Richard
    Dobyns, Emily L.
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U76 - U76
  • [40] PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
    HIRSH, J
    MODERN CONCEPTS OF CARDIOVASCULAR DISEASE, 1984, 53 (05) : 25 - 29
12345